{
  "ticker": "RHY",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02970041",
  "id": "02970041",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250717",
  "time": "0847",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250717/pdf/06lw5ncxggdwls.pdf",
  "summary": "- **Strategic Pilot Program** secured for geneTypeTM with a leading Australian pathology provider.  \n- **Key Milestone**: First domestic commercial partnership since geneTypeTM acquisition.  \n- **Expected Impact**: Sets foundation for broader commercial rollout and potential future revenue growth.  \n\nNo financial figures, capital structure changes, or trading-sensitive details disclosed. Focus is on commercial partnership progress.",
  "usage": {
    "prompt_tokens": 1189,
    "completion_tokens": 76,
    "total_tokens": 1265,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-16T22:50:48.189445"
}